Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Macter International Limited

Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx248product presentations
G91generic molecules
DF11dosage-form groups
TA4therapeutic areas
PKR248current price records
REG201registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage94%
priced packs safely normalized per unit
Comparable-market coverage79%
products with at least one like-for-like comparator
Portfolio intelligence

Therapeutic mix

Unclassified234 products · 94%
Proton pump inhibitors4 products · 2%
Third-generation cephalosporins4 products · 2%
Fluoroquinolone antibacterials3 products · 1%
HMG-CoA reductase inhibitors3 products · 1%
Formulation footprint

Dosage forms

Tablet113 products
Injection64 products
Suspension24 products
Capsule17 products
Inhalation11 products
Infusion6 products
Syrup4 products
Vaccine4 products
Drops3 products
Cream1 products
Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2714% of comparable products
Near market median87within ±5% of median
Above market median8342% of comparable products
Lowest-price equivalents20ties included
Company median price position +3.5% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Regulatory & price activity

Observed database signals

Registration numbers201
Price-history records291
Products with price history37
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date29 Jul 2026
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

248 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Mac-Mether Artemether 80 mg Injection 6's 055950 PKR 1,189.62 PKR 198.27/vial/unit Near median
Mac-Mether Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 055752 PKR 660.90 PKR 41.31/tablet 6% above median
Macazid Gliclazide 80 mg Tablet 20's 010910 PKR 114.76 PKR 5.74/tablet 46% below median
Maccillin Ampicillin 500 mg Injection 10's 026276 PKR 619.59 PKR 61.96/vial/unit 25% below median
Maccillin Ampicillin 250 mg Injection 10's 026275 PKR 405.22 PKR 40.52/vial/unit 37% below median
Macdronic Zoledronic acid 5 mg/100 mL Solution for infusion 1 080656 PKR 30,876.73 No comparator
Macdronic Zoledronic acid 4 mg/5 mL Injection 1's 079757 PKR 34,920.25 PKR 34,920.25/vial/unit No comparator
Macletra Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 101308 PKR 12,331.98 PKR 102.77/tablet 7% above median
Maclinza Daclatasvir 30 mg Tablet 28's 084772 PKR 5,710.84 PKR 203.96/tablet 6% above median
Maclinza Daclatasvir 60 mg Tablet 28's 084773 PKR 9,344.27 PKR 333.72/tablet Near median
Maclusa Sofosbuvir + Velpatasvir 400 mg + 100 mg Tablet 28's 086972 PKR 20,176.07 PKR 720.57/tablet Near median
Macprofen Ibuprofen 400 mg Tablet 200's 006479 PKR 389.61 PKR 1.95/tablet 44% below median
Macprofen Ibuprofen 200 mg Tablet 500's 006478 PKR 1,296.89 PKR 2.59/tablet 13% above median
Macprofen Ibuprofen 600 mg Tablet 24's 011658 PKR 60.92 PKR 2.54/tablet 60% below median
Macprofen Ibuprofen 600 mg Tablet 60's 011658 PKR 154.48 PKR 2.57/tablet 59% below median
Macprofen Ibuprofen 100 mg/5 mL Syrup 90ml 011677 PKR 80.78 PKR 0.90/mL Near median
Macticort Inhaler Beclomethasone dipropionate 50 mcg Inhaler 200 actuation 047267 PKR 299.47 No comparator
Macticort Inhaler Beclomethasone dipropionate 250 mcg Inhaler 200 MD 045159 PKR 561.77 No comparator
Mactran Sulfamethoxazole + Trimethoprim 400 mg + 80 mg Tablet 200's 007698 PKR 305.81 PKR 1.53/tablet 44% below median
Mactran Sulfamethoxazole + Trimethoprim 400 mg + 80 mg Tablet 20×10 007698 PKR 331.29 PKR 1.66/tablet 39% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.